Pain News and Research

Latest Pain News and Research

Emergent Financial Group raises $11.8M for Tenex Health

Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.

6 Feb 2012

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

6 Feb 2012

Clinuvel submits SCENESSE MAA to EMA for treatment of erythropoietic protoporphyria

Clinuvel Pharmaceuticals Limited today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class drug SCENESSE (afamelanotide 16mg implant) to the European Medicines Agency.

6 Feb 2012

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

With its roster of corporate sponsors and the pink ribbons that lend a halo to almost any kind of product you can think of, the Susan G. Komen for the Cure foundation has a longstanding reputation as a staunch protector of women's health. That reputation suffered a grievous, perhaps mortal, wound this week from the news that Komen, the world's largest breast cancer organization, decided to betray that mission.

5 Feb 2012

Study to evaluate vitaminD3, omega3 and home exercise in preventing age-related chronic diseases

In Europe, the number of seniors aged 70 and over will increase by 40% in the next 20 years, while those aged 80 and over will more than double. Health authorities and the medical community expect a corresponding increase in the number of people suffering costly and debilitating age-related chronic diseases such as osteoporosis, arthritis, heart and lung diseases and dementia.

3 Feb 2012

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.

3 Feb 2012

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.

3 Feb 2012

Dr. Reddy’s third quarter revenues increase 46% to $522 million

Dr. Reddy's Laboratories Ltd. today announced its unaudited consolidated financial results for the quarter ended December 31, 2011 under International Financial Reporting Standards.

3 Feb 2012

CNA/NNU announce support for Millionaires Tax of 2012 initiative

With ongoing cuts to healthcare, education, and other basic services, and greater national income disparity than during the Depression, the California Nurses Association/National Nurses United today announced its support for the Millionaires Tax of 2012 initiative.

3 Feb 2012

Study to determine causes and impact of hyperkyphosis

The Institute for Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical School, today announced that Dr. Lisa Samelson and the Institute were awarded a $2.7 million grant from the National Institute on Aging to conduct a five-year study to better understand the cause of hyperkyphosis, a condition that causes extreme forward curvature of the spine.

3 Feb 2012

EUSA Pharma acquires ASPAREC development and commercialization rights

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has acquired the exclusive worldwide development and commercialization rights to ASPAREC for the treatment of acute lymphoblastic leukemia (ALL) from Alizé Pharma.

3 Feb 2012

New England Journal of Medicine publishes Diamyd Medical's antigen-based diabetes therapy study

An article with the results of Diamyd Medical's European Phase III study of the antigen-based diabetes therapy Diamyd® has been published in the scientific journal the New England Journal of Medicine. The now published results were previously presented at the American Diabetes Association's 71st Scientific Sessions in San Diego, California, USA, on June 28, 2011.

3 Feb 2012

Nuvo launches Synera in the U.S.

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced the U. S. launch of Synera.

3 Feb 2012

Mass. bill would mandate docs to check database before prescribing pain meds

The legislation is expected to come up for a vote in the Massachusetts Senate Thursday. In Florida, the legislature killed a bill to take away prescription rights from doctors awaiting trial on pill-trafficking charges.

2 Feb 2012

Medtronic initiates enrollment in IMPROVE HF Bridge Study

Medtronic, Inc. today announced the initiation and first patient enrollment in a clinical study that will evaluate gaps in the implementation of evidence-based treatment guidelines among chronic heart failure patients post-hospital discharge.

From Medtronic 2 Feb 2012

Takeda, SPI announce that lubiprostone phase 3 trial on OBD meets primary endpoint

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone.

2 Feb 2012

Link between poor neighbourhoods and risk of arthritis

People living in poor neighbourhoods have a higher rate and risk of arthritis - one of the most common causes of disability in the developed world.

2 Feb 2012

Over-exposure to noise can cause more lasting changes to auditory circuitry

We all know that it can take a little while for our hearing to bounce back after listening to our iPods too loud or attending a raucous concert. But new research at the University of Michigan Health System suggests over-exposure to noise can actually cause more lasting changes to our auditory circuitry - changes that may lead to tinnitus, commonly known as ringing in the ears.

2 Feb 2012

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.

1 Feb 2012

Brief 10-minute massage helps reduce inflammation in muscle

Researchers at McMaster University have discovered a brief 10-minute massage helps reduce inflammation in muscle.

1 Feb 2012

Pain News and Research

Latest Pain News and Research

Emergent Financial Group raises $11.8M for Tenex Health

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

Clinuvel submits SCENESSE MAA to EMA for treatment of erythropoietic protoporphyria

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

Study to evaluate vitaminD3, omega3 and home exercise in preventing age-related chronic diseases

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

Dr. Reddy’s third quarter revenues increase 46% to $522 million

CNA/NNU announce support for Millionaires Tax of 2012 initiative

Study to determine causes and impact of hyperkyphosis

EUSA Pharma acquires ASPAREC development and commercialization rights

New England Journal of Medicine publishes Diamyd Medical's antigen-based diabetes therapy study

Nuvo launches Synera in the U.S.

Mass. bill would mandate docs to check database before prescribing pain meds

Medtronic initiates enrollment in IMPROVE HF Bridge Study

Takeda, SPI announce that lubiprostone phase 3 trial on OBD meets primary endpoint

Link between poor neighbourhoods and risk of arthritis

Over-exposure to noise can cause more lasting changes to auditory circuitry

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Brief 10-minute massage helps reduce inflammation in muscle

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Pain News and Research

Latest Pain News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in